article thumbnail

Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype

Bill of Health

In 2013, for instance, I published an essay titled “ A Declaration of Psychedelic Studies ,” which began with these words: “The scientific research community is in the midst of a ‘psychedelic renaissance,’ but sanctioned platforms for mainstream discussion are heavily weighted in the direction of objective scientific research.

article thumbnail

Introducing Affiliated Researchers for the Project on Psychedelics Law and Regulation

Bill of Health

(he/him or they/them) has been personally utilizing psychedelics and other substances in celebratory and spiritual contexts for over fifteen years, and has been actively participating in the drug policy reform movement since 2013.

FDA 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – Spring

SQA

ANVISA’s RDC 665/2022 (link in Portuguese) replaces previous regulations, including RDC 16/2013 and IN 08/2013, and went into effect on 02 May 2022. ANVISA has issued a new resolution that updates Brazilian Good Manufacturing Practices (BGMP) for medical devices and in vitro diagnostic (IVD) products.

FDA 75
article thumbnail

Can Children Consent to the COVID Vaccine? The Case of Foster Care and Juvenile Justice

Bill of Health

439, 448 (2013). [15] Sugarman, 566 F.2d 2d 817, 825 (2d Cir. 13] San Antonio Indep. Rodriguez, 411 U.S. 1, 35 (1973). [14] 14] Erin C. Fuse Brown, Developing a Durable Right to Health Care , 14 Minn. & Tech. 15] Emily Parker, Constitutional Obligations for Public Education , Educ.

article thumbnail

Malarkey ? The Ten Worst Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Bexis’ amicus efforts this year in Mallory obviously came to naught, and we’ve had our own cases on this list before (see, e.g. , 2013-2 and 2021-10 ). If you’ve been burned by any of these judicial debacles, we sympathize. A lawyer who never loses doesn’t litigate hard cases. The penalty did not hold up, but the duty did.

FDA 52
article thumbnail

Always Liability Increases (ALI)?  Not Yet with Medical Monitoring.

Drug & Device Law

Another motion reflected Bexis original position (but wasn’t Bexis’ motion), that the Institute should prepare black letter, comments and reporters’ notes for both sides of this issue, similarly to the manner in which the same draft handled the question of patient-oriented versus physician-oriented standards for informed consent.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Plaintiff knew about it, too, since he signed an informed consent document mentioning it. The G/N MDL was created in 2013 and mostly settled in 2016. In Cates the plaintiff encountered an unusual – so unusual as to be called “paradoxical” − but known, adverse reaction. The device labeling specifically mentioned it. 13) McGee v.

FDA 105